BFRI
Biofrontera Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
0.93
close · 2026-10-29
value
96
cheaper than peers96
quality
11
stronger fundamentals11
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
41 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 0.39× | 99 |
| forward P/E | 2.17× | 98 |
| price to book | 2.22× | 64 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 17.4% | 74 |
| debt to equity | 127.2% | 30 |
| operating margin | -39.0% | 11 |
| return on equity | -339.0% | 1 |
4 of 4 measures available
Facts
| market cap | $14M |
| free cash flow | $1.5M |
| employees | 84 |
| first trade | 2021-10-29 |
| next earnings | 2026-08-13 |
| fundamentals updated | 2026-08-14 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.90 | -3.22 | -13.02 | -0.48 |
| free cash flow | -$13.4M | -$10.3M | -$24.9M | -$16.2M |
| net income | -$10.5M | -$17.8M | -$20.1M | -$640,000 |
| revenue | $41.7M | $37.3M | $34.1M | $28.7M |
| unusual items | $901,000 | $1.4M | $3.0M | $21.9M |